Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Tacrolimus therapy"'
Autor:
Mary S. Dietrich, Micah Skeens, Nancy Ryan-Wenger, Mary Jo Gilmer, Terrah Foster Akard, Shelagh A. Mulvaney
Publikováno v:
Clinical Journal of Oncology Nursing. 24:E57-E64
Background Researchers have estimated that about 50% of pediatric patients with chronic illness adhere to tacrolimus therapy, a medication responsible for preventing critical side effects in patients undergoing hematopoietic stem cell transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d5570d05aedb74688c42ad4ad0a790c
https://doi.org/10.1188/20.cjon.e57-e64
https://doi.org/10.1188/20.cjon.e57-e64
Autor:
Chengning Zhang, Yanggang Yuan, Bo Zhang, Zhimin Huang, Suyan Duan, Jingfeng Zhu, Bin Sun, Miao Guo, Changying Xing
Publikováno v:
Pharmacogenomics and Personalized Medicine. 13:141-149
Background Tacrolimus (TAC) is beneficial for patients with idiopathic membranous nephropathy (IMN). It has a narrow therapeutic concentration range and many factors influence TAC blood concentration. CYP3A5 is the most important enzyme in TAC metabo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dab8d74cfbac581bfca40320f38bf100
https://doi.org/10.2147/pgpm.s247892
https://doi.org/10.2147/pgpm.s247892
Publikováno v:
Renal Failure
Renal Failure, Vol 41, Iss 1, Pp 673-681 (2019)
Renal Failure, Vol 41, Iss 1, Pp 673-681 (2019)
BACKGROUND Guidelines recommend classical combined therapy of steroid and cyclophosphamide (CYC) for patients with idiopathic membranous nephropathy (IMN), while it is associated with severe adverse effects. AIMS We conducted an observational and ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e2ac2a907627fdc37acd0106c03dd5e
https://doi.org/10.1080/0886022x.2019.1637758
https://doi.org/10.1080/0886022x.2019.1637758
Publikováno v:
Dermatologic Therapy. 34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87259da540d1b0162d601b13791c0a5c
https://doi.org/10.1111/dth.14782
https://doi.org/10.1111/dth.14782
Publikováno v:
PharmacotherapyReferences. 41(1)
Background Tacrolimus therapy in solid organ transplant (SOT) recipients is challenging due to its narrow therapeutic window and pharmacokinetic variability both between patients and within a single patient. Intrapatient variability (IPV) of tacrolim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44d17bce27a7af4e9d329f4c114f8378
https://pubmed.ncbi.nlm.nih.gov/33131078
https://pubmed.ncbi.nlm.nih.gov/33131078
Publikováno v:
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 19(7)
Objectives Tacrolimus is currently one of the most commonly used immunosuppressant agents to prevent rejection in organ transplant. Although modern immunosuppressive agents have been successful, rejection cannot be completely prevented. Therefore, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d26285398b96efb8c32eafed863d9e87
https://pubmed.ncbi.nlm.nih.gov/32281529
https://pubmed.ncbi.nlm.nih.gov/32281529
Autor:
Frank Stifft
Individualization of tacrolimus treatment to prevent rejection in kidney transplantation is pivotal. It has been shown that: • Tacrolimus can also be administered by a suppository, contrary to application under the tongue. • Altered tacrolimus bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d227a7091d9bced97a43219839c3cb1
https://cris.maastrichtuniversity.nl/en/publications/1320be0f-b677-4023-95dd-07ea7350cbcd
https://cris.maastrichtuniversity.nl/en/publications/1320be0f-b677-4023-95dd-07ea7350cbcd
Publikováno v:
Pharmaceutical and Biosciences Journal. :33-38
With the availability of many immunosuppressive drugs for treatment of solid organ transplantation increase to a life span of patients who is receiving tacrolimus separately for End Stage of liver, heart and lung, kidney. But after all success of sol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16722966fd281938c1a5ba61ed431ed2
https://doi.org/10.20510/ukjpb/6/i1/173528
https://doi.org/10.20510/ukjpb/6/i1/173528
Autor:
Yuri Miyanomae, Takenori Tozawa, Hajime Hosoi, Tomohiro Chiyonobu, Daisuke Kaneda, Masafumi Morimoto, Tamaki Ueno, Akira Nishimura
Publikováno v:
Neuropediatrics. 49:200-203
Seronegative myasthenia gravis (MG) is a generalized form of MG that is diagnosed on the basis of clinical symptoms, electrophysiological testing, and pharmacological responses, in the absence of a seropositive status for anti-acetylcholine receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14208d687c662d973754ad99a6d0424
https://doi.org/10.1055/s-0037-1618591
https://doi.org/10.1055/s-0037-1618591
Publikováno v:
Transplantation Proceedings. 51:1169-1171
Parvovirus B19 infection is common in childhood. The clinical presentations range from benign to life threatening. The literature shows that the clinical presentation is influenced by the patient's age and the presence of chronic disease such as chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ccd20ab1f03223f8daf2f27ae8ce72
https://doi.org/10.1016/j.transproceed.2019.01.084
https://doi.org/10.1016/j.transproceed.2019.01.084